[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614284":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":39,"responsibleParty":52,"collaborators":54,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":25,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":80,"overallStatus":82,"whyStopped":25,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active Treatment","ACTIVE_COMPARATOR","Active treatment with kTMP for 18 weeks",[13],"Device: kTMP 18 weeks",{"label":15,"type":6,"description":16,"interventionNames":17},"Crossover Treatment","Initial 9 weeks will receive sham kTMP treatment, followed by 9 weeks of active kTMP treatment.",[18],"Device: kTMP sham stimulation 9 weeks + active stimulation 9 weeks",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","kTMP sham stimulation 9 weeks + active stimulation 9 weeks","kTMP 9 weeks sham-kTMP stimulation, followed by 9 weeks active kTMP stimulation",[15],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"kTMP 18 weeks","Participants receive kTMP active stimulation for 18 weeks",[9],[31],{"name":32,"affiliation":5,"role":33},"Karunesh Ganguly, MD, PhD","PRINCIPAL_INVESTIGATOR",[35],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","415-514-1252","karunesh.ganguly@ucsf.edu",[40],{"facility":5,"status":25,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":25},"San Francisco","California","94158","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-122.41942,37.77493,{"lat":50,"lon":49},{"type":53,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[55],{"name":56,"class":57},"National Institute of Neurological Disorders and Stroke (NINDS)","NIH","100614284","ktmp-in-chronic-stroke-100614284",false,"NCT07277595","kTMP in Chronic Stroke","KTMP: A Novel Method of Non-invasive Brain Stimulation to Enhance Motor Function in Chronic Stroke Patients.","KULMINATE","Inclusion Criteria:\n\n* Adults age 18-80 years old who have had a stroke resulting in hemiplegia\n* Ability to communicate, understand, and give appropriate consent\n* Other criteria may apply\n\nExclusion Criteria:\n\n* Significant cognitive impairment\n* inability to adhere to the study protocol or provide informed consent\n* pregnancy\n* additional criteria may apply","ALL","18 Years","80 Years",{"count":70,"type":71},100,"ESTIMATED","INTERVENTIONAL",[74],"NA","kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm\u002Fhand rehabilitation in patients who have been disabled by stroke.",[77,78,79],"Stroke","Chronic Stroke Patients","Arm Weakness as a Consequence of Stroke",[81],"transcranial magnetic stimulation","NOT_YET_RECRUITING","2026-05-01",{"date":85,"type":86},"2026-05-06","ACTUAL",{"date":88,"type":71},"2026-07-01",{"date":90,"type":71},"2030-08-01",{"name":5,"class":6},1]